The increased inflammatory cytokine levels found in the SG-/- tumour tissue may be due to a decreased serglycin-dependent proteolytical degradation of these cytokines, possibly owing to reduced mast cell protease activity[4, 6]. Here, SRGN is linked to neoplasm.